| Date | Source | Headline | |
|---|---|---|---|
| 22nd Mar 2024 | 9:21 am | RNS | Annual Financial Report and Notice of AGM |
| 13th Mar 2024 | 9:42 am | RNS | Director/PDMR Shareholding |
| 7th Mar 2024 | 1:52 pm | RNS | Director/PDMR Shareholding |
| 1st Mar 2024 | 10:17 am | RNS | Total Voting Rights |
| 22nd Feb 2024 | 7:00 am | RNS | Final Results |
| 5th Feb 2024 | 8:46 am | RNS | Notice of Results |
| 1st Feb 2024 | 6:22 pm | RNS | Agreement in Principle for US Opioid Settlement |
| 1st Feb 2024 | 12:08 pm | RNS | Total Voting Rights |
| 2nd Jan 2024 | 3:24 pm | RNS | Total Voting Rights |
| 29th Dec 2023 | 7:00 am | RNS | Company Secretary Change |
| 1st Dec 2023 | 7:00 am | RNS | Total Voting Rights |
| 2nd Nov 2023 | 7:00 am | RNS | Trading Statement |
| 2nd Oct 2023 | 10:13 am | RNS | Block listing Interim Review |
| 2nd Oct 2023 | 10:04 am | RNS | Total Voting Rights |
| 1st Sep 2023 | 7:00 am | RNS | Total Voting Rights |
| 31st Aug 2023 | 4:14 pm | RNS | Director/PDMR Shareholding |
| 11th Aug 2023 | 2:00 pm | RNS | Director/PDMR Shareholding |
| 10th Aug 2023 | 4:53 pm | RNS | Director/PDMR Shareholding |
| 3rd Aug 2023 | 7:00 am | RNS | Half-year Report |
| 17th Jul 2023 | 9:11 am | RNS | Notice of Results |
| 14th Jun 2023 | 10:03 am | RNS | Holding(s) in Company |
| 8th Jun 2023 | 10:25 am | RNS | Director/PDMR Shareholding |
| 31st May 2023 | 3:20 pm | RNS | Director/PDMR Shareholding |
| 23rd May 2023 | 4:14 pm | RNS | Holding(s) in Company |
| 17th May 2023 | 9:56 am | RNS | Director/PDMR Shareholding |
| 2nd May 2023 | 10:53 am | RNS | Total Voting Rights |
| 28th Apr 2023 | 3:25 pm | RNS | Result of AGM |
| 28th Apr 2023 | 7:00 am | RNS | Trading Statement |
| 24th Apr 2023 | 4:15 pm | RNS | Director/PDMR Shareholding |
| 12th Apr 2023 | 7:00 am | RNS | Directorate Change |
| 3rd Apr 2023 | 9:27 am | RNS | Block listing Interim Review |
| 3rd Apr 2023 | 9:19 am | RNS | Total Voting Rights |
| 16th Mar 2023 | 10:17 am | RNS | Annual Financial Report and Notice of AGM |
| 2nd Mar 2023 | 9:30 am | RNS | Total Voting Rights |
| 23rd Feb 2023 | 7:00 am | RNS | Final Results |
| 17th Feb 2023 | 10:20 am | RNS | Holding(s) in Company |
| 7th Feb 2023 | 9:36 am | RNS | Notice of Results |
| 1st Feb 2023 | 10:18 am | RNS | Total Voting Rights |
| 18th Jan 2023 | 10:16 am | RNS | Director/PDMR Shareholding |
| 18th Jan 2023 | 9:39 am | RNS | Holding(s) in Company |
| 17th Jan 2023 | 11:58 am | RNS | Holding(s) in Company |
| 10th Jan 2023 | 3:42 pm | RNS | Additional Listing |
| 10th Jan 2023 | 9:20 am | RNS | Director/PDMR Shareholding |
| 3rd Jan 2023 | 9:23 am | RNS | Total Voting Rights |
| 3rd Jan 2023 | 7:00 am | RNS | Hikma launches sodium oxybate in the US |
| 1st Dec 2022 | 9:24 am | RNS | Total Voting Rights |
| 30th Nov 2022 | 7:00 am | RNS | Hikma Injectables Portugal site visit |
| 22nd Nov 2022 | 11:38 am | RNS | Holding(s) in Company |
| 17th Nov 2022 | 9:50 am | RNS | Holding(s) in Company |
| 3rd Nov 2022 | 7:00 am | RNS | Trading Statement |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.